About Aiforia

Pathologists are pivotal to the healthcare system, investigating and diagnosing patient samples to guide medical treatment. Ageing populations and rising rates of disease like cancer are creating a burden on healthcare systems around the world1. The prevalence of cancer is expected to increase by 47.4% between 2020 and 20402 while the share of the population 65 years or over is expected to increase from 9.3% in 2020 to around 16.0% in 2050 globally.

These factors create an additional burden to pathologists, an already underrepresented group of healthcare professionals. Less medical doctors are specializing in pathology4 while sample numbers are on the rise, creating an imbalance. Exacerbating this disparity is the fact that pathologists have had to rely on the same technology for the past 150 years5; manual slide analysis with microscopes is slow, manual, and prone to variability.

Around the world pathologists are overworked, patients are waiting for a long time to receive results and are in some cases administered ineffective treatments due to misdiagnosis or the inability to administer personalized treatment. Aiforia believes that the industry is ready for paradigm shifting technology to decrease the burden experienced by pathologists and patients alike.